Table 1.
Baseline (visit 1) | Week 4 (visit 2) | Week 8 (visit 3) | Week 12 (visit 4) | Week 24 (visit 5) | |
---|---|---|---|---|---|
Primary outcomes | |||||
12-Week continuous abstinence for weeks 9–12 | x | x | |||
Secondary outcomes | |||||
Sustained smoking reduction for weeks 9–12 | x | x | |||
24-Week continuous abstinence for weeks 9–24 | x | x | x | ||
Sustained smoking reduction for weeks 9–24 | x | x | x | ||
Vital signs (BP and HR) | x | x | x | x | |
Weight | x | x | x | x | |
SANS and SAPS | x | x | x | x | |
Adoption rate and adherence to product use | x | x | x | ||
AEs | x | x | x | x | |
mCEQ | x | x | x | x | |
CO | x | x | x | x | x |
FTCD | x |
AEs = adverse events; BP = blood pressure; CO = exhaled carbon monoxide; FTCD = Fagerstrom test for cigarette dependence; HR = heart rate; mCEQ = Modified Cigarette Evaluation Questionnaire; SANS = Scale for the Assessment of Negative Symptoms; SAPS = Scale for the Assessment of Positive Symptoms.